IP Library Granted Patent US 10,675,588
Granted Patent B2
US 10,675,588 · App. 15/561,579 · Granted Jun 9, 2020

Method of purifying a biological material of interest in a sample using nanofiber ultrafiltration membranes operated in tangential flow filtration mode

Inventors: William Cataldo (Bradford, MA); Mikahil Kozlov (Lexington, MA); Alex Xenopoulos (Cambridge, MA); Dennis Aquino (Chelmsford, MA); Clifton Ngan (Chelmsford, MA)
Assignee: EMD Millipore Corporation
B01D61/145B01D39/1623B01D67/0004B01D71/54B01D71/56C07K1/34B01D2239/025B01D2315/16B01D2323/39
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,675,588
App. No.
15/561,579
Granted
Jun 9, 2020
Kind
B2
Abstract

Embodiments described herein relate to electrospun nanofiber ultrafiltration membrane compositions capable of operating in tangential filtration mode and methods of using the same.

Claims (12)

1. Method of purifying a biological material of interest in a sample comprising:

a. providing a sample containing the biological material of interest having a molecular weight equal to or greater than 500 K Da, wherein the biological material of interest is selected from a therapeutic protein, a conjugated polysaccharide vaccine and a virus-like particle;

b. contacting the sample in tangential filtration (TFF) mode with an electrospun nanofiber membrane composition comprising nylon nanofibers having an average fiber diameter less than 15 nm, thereby resulting in a permeate and a retentate; and

c. collecting the retentate containing the biological material of interest, thereby purifying the biological material of interest.

2. The method of claim 1 , wherein the method results in an increase in the concentration of the biological material of interest.

3. The method of claim 1 , wherein the electrospun nanofiber composition exhibits a higher water permeability in TFF mode compared to a solution cast polymeric membrane.

4. The method of claim 1 , wherein the electrospun nanofiber membrane composition exhibits a higher flux in TFF mode compared to a solution cast polymeric membrane.

5. The method of claim 1 , wherein the collecting step comprises diafiltration.

6. The method of claim 1 , wherein the electrospun nanofiber membrane composition is made from Nylon-6.

7. The method of claim 1 , wherein the purified biological material of interest has a 90% yield or greater than 90% yield.

8. The method of claim 1 , wherein the electrospun nanofiber membrane composition is incorporated into a device suitable for TFF.

9. The method of claim 8 , wherein the device is a cassette or a spiral wound device.

Assignments (3)
CHANGE OF ADDRESS Recorded Feb 15, 2018
From: EMD MILLIPORE CORPORATION
To: EMD MILLIPORE CORPORATION
Reel/Frame 045341/0166 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE. PREVIOUSLY RECORDED AT REEL: 043852 FRAME: 0671. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jan 31, 2018
From: CATALDO, WILLIAM; KOZLOV, MIKHAIL; XENOPOULOS, ALEX; AQUINO, DENNIS; NGAN, CLIFTON
To: EMD MILLIPORE CORPORATION
Reel/Frame 045209/0676 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2017
From: CATALDO, WILLIAM; KOZLOV, MIKHAIL; XENOPOULOS, ALEX; AQUINO, DENNIS; NGAN, CLIFTON
To: EMD MILLIPORE CORPORATION
Reel/Frame 043852/0671 →
Continuity (2)
Provisional Application 62148793 · Apr 17, 2015
Related Publication 20180085710A1 · Mar 29, 2018
Cited By (1)
US 12,186,713